Association of Vaccinia Virus Fusion Regulatory Proteins with the Multicomponent Entry/Fusion Complex
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
The proteins encoded by the A56R and K2L genes of vaccinia virus form a heterodimer (A56/K2) and have a fusion regulatory role as deletion or mutation of either causes infected cells to form large syncytia spontaneously. Here, we showed that syncytia formation is dependent on proteins of the recently described entry fusion complex (EFC), which are also required for virus-cell fusion and low-pH-triggered cell-cell fusion. This finding led us to consider that A56/K2 might prevent fusion by direct or indirect interaction with the EFC. To test this hypothesis, we made a panel of recombinant vaccinia viruses that have a tandem affinity purification tag attached to A56, K2, or the A28 EFC protein. Interaction between A56/K2 and the EFC was demonstrated by their copurification from detergent-treated lysates of infected cells and identification by mass spectrometry or Western blotting. In addition, a purified soluble transmembrane-deleted form of A56/K2 was shown to interact with the EFC. Tagged A56 did not interact with the EFC in the absence of K2, nor did tagged K2 interact with the EFC in the absence of A56. The finding that both A56 and K2 are required for efficient binding to the EFC fits well with prior experiments showing that mutation of either A56 or K2 results in spontaneous fusion of infected cells. Because A56 and K2 are located on the surface of infected cells, they are in position to interact with the EFC of released progeny virions and prevent back-fusion and syncytia formation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As the name implies, TAP uses a dual epitope tag for successive immunoaffinity isolations and has been applied to interactions within virus-infected cells (51–54).”
From The Impact of Mass Spectrometry–Based Proteomics on Fundamental Discoveries in Virology (2014) · cites this paper as [51]
Citations
Cites
Lippincott-Schwartz, J., Yuan, L. C., Bonifacino, J. S., & Klausner, R. D. (1989) · Cell · doi:10.1016/0092-8674(89)90685-5 · Cited by 1,687 · cited 1×
“To prevent secretion and potentially allow more opportunity for K2 to interact with the EFC, we employed brefeldin A, an antibiotic that disrupts the Golgi apparatus (10, 21).”
Brefeldin A redistributes resident and itinerant Golgi proteins to the endoplasmic reticulum.
Doms, R. W., Russ, G., & Yewdell, J. W. (1989) · The Journal of cell biology · doi:10.1083/jcb.109.1.61 · Cited by 586 · cited 1×
“To prevent secretion and potentially allow more opportunity for K2 to interact with the EFC, we employed brefeldin A, an antibiotic that disrupts the Golgi apparatus (10, 21).”
The formation and function of extracellular enveloped vaccinia virus
Smith, G. L., Vanderplasschen, A., & Law, M. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-12-2915 · Cited by 559 · cited 1×
“A second type of infectious particle, known as the enveloped virion (EV), is released from the intact cell by exocytosis and is essentially an MV with an additional membrane that is derived from trans-Golgi or endosomal cisternae and discarded before or during the entry process (20, 33).”
In A Nutshell: Structure and Assembly of the Vaccinia Virion
Condit, R. C., Moussatche, N., & Traktman, P. (2006) · Advances in Virus Research · doi:10.1016/s0065-3527(06)66002-8 · Cited by 384 · cited 1×
“The simplest infectious particle, which can be released by cell lysis, is termed a mature virion (MV); it consists of a core structure containing the DNA genome, numerous enzymes, and structural components surrounded by a lipoprotein membrane, likely derived from the endoplasmic reticulum and within which are embedded…”
Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins
Kotwal, G. J., & Moss, B. (1988) · Nature · doi:10.1038/335176a0 · Cited by 346 · cited 1×
“C3 is a secreted modulator of complement activation (17, 18), I1 is a DNA telomere binding protein (8, 16), and O2 is a nonessential glutaredoxin (1, 27).”
Self-citationInhibition of the Complement Cascade by the Major Secretory Protein of Vaccinia Virus
Kotwal, G. J., Isaacs, S. N., McKenzie, R., Frank, M. M., & Moss, B. (1990) · Science · doi:10.1126/science.2237434 · Cited by 321 · cited 1×
“C3 is a secreted modulator of complement activation (17, 18), I1 is a DNA telomere binding protein (8, 16), and O2 is a nonessential glutaredoxin (1, 27).”
Self-citationBlasco, R., & Moss, B. (1991) · Journal of Virology · doi:10.1128/jvi.65.11.5910-5920.1991 · Cited by 317 · cited 2×
“fusion due to absence of A56 (and presumably K2) depend on the production of extracellular virus particles (3).”
Self-citationPoxvirus entry and membrane fusion
Moss, B. (2006) · Virology · doi:10.1016/j.virol.2005.09.037 · Cited by 288 · cited 2×
“The simplest infectious particle, which can be released by cell lysis, is termed a mature virion (MV); it consists of a core structure containing the DNA genome, numerous enzymes, and structural components surrounded by a lipoprotein membrane, likely derived from the endoplasmic reticulum and within which are embedded…”
Self-citationPreparation of Cell Cultures and Vaccinia Virus Stocks
Earl, P. L., Cooper, N., Wyatt, L. S., Moss, B., & Carroll, M. W. (1998) · Current Protocols in Protein Science · doi:10.1002/0471140864.ps0512s13 · Cited by 282 · cited 1×
“Virus stocks were prepared as described previously (11).”
Self-citationSelection of recombinant vaccinia viruses on the basis of plaque formation
Blasco, R., & Moss, B. (1995) · Gene · doi:10.1016/0378-1119(95)00149-z · Cited by 182 · cited 2×
“described plaque selection system (4).”
Self-citation
Research works printed but not linked: 1
- Moss, B. 2001. Poxviridae: the viruses and their replication, p. 2849-2883. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
Cited by
Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme
White, J. M., Delos, S. E., Brecher, M., & Schornberg, K. (2008) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230802058320 · Cited by 892
“Related models may apply to poxviruses, which employ even more proteins in their fusion complexes (Table 1) (Wagenaar and Moss, 2007).”
MethodA Preliminary Assessment of Silver Nanoparticle Inhibition of Monkeypox Virus Plaque Formation
Rogers, J. V., Parkinson, C. V., Choi, Y. W., Speshock, J. L., & Hussain, S. M. (2008) · Nanoscale Research Letters · doi:10.1007/s11671-008-9128-2 · Cited by 453
Vaccinia virus morphogenesis and dissemination
Roberts, K. L., & Smith, G. L. (2008) · Trends in Microbiology · doi:10.1016/j.tim.2008.07.009 · Cited by 278
Poxvirus Cell Entry: How Many Proteins Does it Take?
Moss, B. (2012) · Viruses · doi:10.3390/v4050688 · Cited by 264
“Although referred to as fusion from within, syncytia formation is dependent on the formation and externalization of virions and on components of the EFC suggesting that the phenomenon has features related to virus entry [124].”
BackgroundSelf-citationSmallpox vaccines: targets of protective immunity
Moss, B. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00975.x · Cited by 259
“complement regulatory protein C3 (80, 81) lack transmem-”
BackgroundSelf-citationRepulsion of Superinfecting Virions: A Mechanism for Rapid Virus Spread
Doceul, V., Hollinshead, M., van der Linden, L., & Smith, G. L. (2010) · Science · doi:10.1126/science.1183173 · Cited by 230
Virological and Immunological Outcomes of Coinfections
Kumar, N., Sharma, S., Barua, S., Tripathi, B. N., & Rouse, B. T. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00111-17 · Cited by 228
Membrane fusion during poxvirus entry
Moss, B. (2016) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2016.07.015 · Cited by 170
“The A56-K2 complex interacts with the A16-G9 EFC subcomplex but not with A16 or G9 alone [65,81].”
BackgroundSelf-citationBenhnia, M. R., McCausland, M. M., Moyron‐Quiroz, J., Laudenslager, J., Granger, S. W., Rickert, S., Koriazova, L. K., Kubo, R. T., Kato, S., & Crotty, S. (2008) · Journal of Virology · doi:10.1128/jvi.01797-08 · Cited by 144
“VCP is also bound to A56, an EV surface protein (34, 94),”
BackgroundVaccinia Virus L1 Protein Is Required for Cell Entry and Membrane Fusion
Bisht, H., Weisberg, A. S., & Moss, B. (2008) · Journal of Virology · doi:10.1128/jvi.00852-08 · Cited by 119
“These proteins are also required for cell-cell fusion triggered by low pH or by mutation of the A56 or K2 protein (30, 38).”
BackgroundSelf-citationHashimoto, Y., Sheng, X., Murray-Nerger, L. A., & Cristea, I. M. (2020) · Nature Communications · doi:10.1038/s41467-020-14586-5 · Cited by 100
Vaccinia virus strain differences in cell attachment and entry
Bengali, Z., Townsley, A. C., & Moss, B. (2009) · Virology · doi:10.1016/j.virol.2009.04.012 · Cited by 88
“…Senkevich and Moss, 2005; Senkevich et al., 2005; Senkevich et al., 2004; Townsley et al., 2005a; Townsley et al., 2005b) and is also required for cell-cell fusion triggered by low pH or mutation of the A56 or K2 proteins (Senkevich et al., 2004; Wagenaar and Moss, 2007; Wagenaar et al., 2008).”
BackgroundSelf-citationPoxvirus Proteomics and Virus-Host Protein Interactions
Vliet, K. V., Mohamed, M. R., Zhang, L., Villa, N., Werden, S. J., Liu, J., & McFadden, G. (2009) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00026-09 · Cited by 91
Benhnia, M. R., McCausland, M. M., Laudenslager, J., Granger, S. W., Rickert, S., Koriazova, L. K., Tahara, T., Kubo, R. T., Kato, S., & Crotty, S. (2009) · Journal of Virology · doi:10.1128/jvi.01593-09 · Cited by 73
“This would be consistent with studies that show titers of anti-A33 and -A56 antibodies in human vaccinees (62, 83) and that a chimpanzee/human fusion MAb against A33 is protective in vivo (16).”
BackgroundInfluentialParekh, P. A., Tang, Z., Turner, P., Moyer, R. W., & Tan, W. (2010) · Analytical Chemistry · doi:10.1021/ac101801j · Cited by 68
The Impact of Mass Spectrometry–Based Proteomics on Fundamental Discoveries in Virology
Greco, T. M., Diner, B. A., & Cristea, I. M. (2014) · Annual Review of Virology · doi:10.1146/annurev-virology-031413-085527 · Cited by 67
“For example, a streptavidin- and calmodulin-binding TAP system was used to isolate the vaccinia virus A56 and K2 proteins, which localize to the cell surface and are required for interaction with the entry fusion complex (51).”
MethodA comparative review of viral entry and attachment during large and giant dsDNA virus infections
Sobhy, H. (2017) · Archives of Virology · doi:10.1007/s00705-017-3497-8 · Cited by 72
Satheshkumar, P. S., & Moss, B. (2009) · Journal of Virology · doi:10.1128/jvi.01744-09 · Cited by 59
Self-citationWagenaar, T. R., Ojeda, S., & Moss, B. (2008) · Journal of Virology · doi:10.1128/jvi.00162-08 · Cited by 58
“The EFC is also required for cell-cell fusion (28, 37), which can be induced by briefly lowering the pH (10, 13) or preventing expression of either the A56 (15, 24) or K2 (17, 34, 38) polypeptide.”
BackgroundMethodSelf-citationTwo Distinct Low-pH Steps Promote Entry of Vaccinia Virus
Townsley, A. C., & Moss, B. (2007) · Journal of Virology · doi:10.1128/jvi.00606-07 · Cited by 48
Self-citationLaliberte, J. P., & Moss, B. (2014) · Journal of Virology · doi:10.1128/jvi.00816-14 · Cited by 48
“The finding that the A56/K2 heterodimer interacts specifically with two interacting proteins of the EFC provided a mechanism for preventing syncytium formation (7, 8).”
BackgroundMethodInfluentialSelf-citationExpression of the A56 and K2 Proteins Is Sufficient To Inhibit Vaccinia Virus Entry and Cell Fusion
Wagenaar, T. R., & Moss, B. (2008) · Journal of Virology · doi:10.1128/jvi.01684-08 · Cited by 47
“Moreover, A56/K2 binds to the EFC through the A16 and G9 subunits (53, 54).”
BackgroundMethodResultInfluentialSelf-citationThe Vaccinia Virus Gene I2L Encodes a Membrane Protein with an Essential Role in Virion Entry
Nichols, R. J., Stanitsa, E. S., Unger, B., & Traktman, P. (2008) · Journal of Virology · doi:10.1128/jvi.01035-08 · Cited by 49
“This interaction is mediated by A16 and G9 (62, 63).”
BackgroundGirgis, N. M., DeHaven, B. C., Fan, X., Viner, K. M., Mohammad, S., & Isaacs, S. N. (2008) · Journal of Virology · doi:10.1128/jvi.02426-07 · Cited by 44
“Although the interaction between the A56-K2 complex and the VACV entry-fusion complex seems to be dependent on both A56 and K2 (45), we found that K2 is not required for the cell surface expression of VCP (Fig.”
BackgroundMethodResultInfluentialCloak and Dagger: Alternative Immune Evasion and Modulation Strategies of Poxviruses
Bidgood, S. R., & Mercer, J. (2015) · Viruses · doi:10.3390/v7082844 · Cited by 52
“These additional membranes contain a set of viral proteins not found in MVs: A33 [88], A34 [89], A36 [90], A56 [91], F12 [92], F13 [93], B5 [94], E2 [95] and K2 [96,97].”
BackgroundDeHaven, B. C., Gupta, K., & Isaacs, S. N. (2011) · Journal of General Virology · doi:10.1099/vir.0.030460-0 · Cited by 42
Nelson, G. E., Wagenaar, T. R., & Moss, B. (2008) · Journal of Virology · doi:10.1128/jvi.00434-08 · Cited by 40
“The postnuclear supernatant was incubated with streptavidin Sepharose, washed, and eluted with biotin as described elsewhere (39).”
MethodSelf-citationTurner, P., & Moyer, R. W. (2008) · Virology · doi:10.1016/j.virol.2008.07.020 · Cited by 40
“The most likely mechanism for this reduction is interaction of SPI-3/A56 with proteins in the entry/fusion complex (Wagenaar and Moss, 2007), with resulting inhibition of virus fusion and entry.”
InfluentialChang, S.-J., Shih, A.-C., Tang, Y.-L., & Chang, W. (2012) · Journal of Virology · doi:10.1128/jvi.06081-11 · Cited by 38
“Both fusion suppressions are overcome by acidic treatment (19, 28), and both fusions require the EFC to execute the fusion step (36, 57, 59).”
BackgroundResultDoceul, V., Hollinshead, M. S., Breiman, A., Laval, K., & Smith, G. L. (2012) · Journal of General Virology · doi:10.1099/vir.0.043943-0 · Cited by 38
“…which also form a complex on the cell surface (Turner & Moyer, 2006) and block IMV entry by binding to components of the IMV entry fusion complex (Wagenaar & Moss, 2007; Wagenaar et al., 2008); and (iii) which proteins on the surface of EEV are needed for interaction with the A33–A36 complex to…”
BackgroundNakatake, M., Kuwano, N., Kaitsurumaru, E., Kurosaki, H., & Nakamura, T. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.12.024 · Cited by 32
DeHaven, B. C., Girgis, N. M., Xiao, Y., Hudson, P. N., Olson, V. A., Damon, I. K., & Isaacs, S. N. (2010) · Journal of Virology · doi:10.1128/jvi.00372-10 · Cited by 26
“To begin to assess how much VCP is bound to A56, a recombinant VACV expressing a TAP-tagged version of A56 (40) was used to coprecipitate VCP.”
BackgroundMethodInfluentialTemporal expression classes and functions of vaccinia virus and mpox (monkeypox) virus genes
Deng, Y., Navarro-Forero, S., & Yang, Z. (2025) · mBio · doi:10.1128/mbio.03809-24 · Cited by 22
Shinoda, K., Wyatt, L. S., & Moss, B. (2010) · Virology · doi:10.1016/j.virol.2010.05.025 · Cited by 18
“Two additional proteins, A56 and K2, are present in both the EVmembrane and the plasmamembrane; they interactwith the A16 and G9 components of the EFC (Wagenaar and Moss, 2007; Wagenaar et al., 2008) and function to prevent fusion of progeny virions with infected cells (Turner andMoyer, 2008;Wagenaar andMoss, 2009) an…”
BackgroundSelf-citationCowpox virus inhibits human dendritic cell immune function by nonlethal, nonproductive infection
Hansen, S. J., Rushton, J. J., Dekonenko, A., Chand, H. S., Olson, G. K., Hutt, J. A., Pickup, D. J., Lyons, C. R., & Lipscomb, M. F. (2011) · Virology · doi:10.1016/j.virol.2011.01.024 · Cited by 18
“VACV and CPXV do not induce syncytia at neutral pH unless conditions favor the inhibition or inactivation of proteins such as the K2L and A56R proteins that suppress cell fusion (Brum et al., 2003; Ichihashi and Dales, 1971; Law and Smith, 1992; Turner and Moyer, 1992; Wagenaar and Moss, 2007; Zhou et al., 1992); but…”
BackgroundVaccinia virus B5 protein affects the glycosylation, localization and stability of the A34 protein
Breiman, A., & Smith, G. L. (2010) · Journal of General Virology · doi:10.1099/vir.0.020677-0 · Cited by 17
“The CEV/EEV outer membrane contains at least six viral proteins: A33 (Roper et al., 1996), A34 (Duncan & Smith, 1992), A56 (Shida, 1986), B5 (Engelstad et al., 1992; Wolffe et al., 1993), F13 (Blasco & Moss, 1991) and K2 (Turner & Moyer, 2006; Wagenaar & Moss, 2007).”
Husain, M., Weisberg, A. S., & Moss, B. (2007) · Virology · doi:10.1016/j.virol.2007.05.015 · Cited by 15
Self-citationChan, W. M., & Ward, B. M. (2012) · Journal of Virology · doi:10.1128/jvi.00249-12 · Cited by 14
“Eight proteins encoded by vaccinia virus, A33 (36), A34 (8), A36 (48), A56 (42), B5 (11, 55), F12 (47, 58), F13 (2), and K2 (46, 49), have been shown to be specific for IEV.”
Satheshkumar, P. S., Chavre, J., & Moss, B. (2013) · Virology · doi:10.1016/j.virol.2013.06.003 · Cited by 13
“Virus entry and syncytium formation require EFC proteins and likely employ a similar mechanism of membrane fusion (Wagenaar and Moss, 2007).”
BackgroundSelf-citationTransport and stability of the vaccinia virus A34 protein is affected by the A33 protein
Breiman, A., Carpentier, D. C. J., Ewles, H. A., & Smith, G. L. (2012) · Journal of General Virology · doi:10.1099/vir.0.049486-0 · Cited by 12
“…at least seven viral proteins: A33 (Roper et al., 1996), A34 (Duncan & Smith, 1992), A56 (Shida, 1986), B5 (Engelstad et al., 1992; Wolffe et al., 1993), F13 (Blasco et al., 1991), K2 (Turner & Moyer, 2006; Wagenaar & Moss, 2007) and VACV complement control protein (DeHaven et al., 2010, 2011).”
Chan, W. M., & Ward, B. M. (2012) · Journal of Virology · doi:10.1128/jvi.00253-12 · Cited by 12
“The vaccinia virus proteins A33 (29), A34 (8), A56 (33), B5 (11, 47), F13 (1), and K2 (37, 40) are found on both the IEV and EV forms, whereas F12 (38, 50) and A36 (39) are found only on the IEV form.”
Chan, W. M., Kalkanoglu, A. E., & Ward, B. M. (2010) · Virology · doi:10.1016/j.virol.2010.09.021 · Cited by 10
“The complex of A56 and K2 are known as fusion regulatory proteins and associate with the entry/fusion complex (Wagenaar and Moss, 2007).”
BackgroundInduction of cell-cell fusion by ectromelia virus is not inhibited by its fusion inhibitory complex
Noam Erez, A., Paran, N., Maik-Rachline, G., Politi, B., Israely, T., Schnider, P., Fuchs, P., Melamed, S., & Lustig, S. (2009) · Virology Journal · doi:10.1186/1743-422x-6-151 · Cited by 10
“5C) since K2 is rapidly secreted in the absence of its membrane anchoring counterpart, namely A56 [4].”
BackgroundCotter, C. A., & Moss, B. (2020) · Journal of Virology · doi:10.1128/jvi.00077-20 · Cited by 8
“The VACV A56/K2 fusion regulatory complex has a dual role in preventing superinfection and syncytium formation by a mechanism suggested to involve an interaction with the VACV EFC (23).”
BackgroundMethodInfluentialSelf-citationHong, G.-C., Tsai, C.-H., & Chang, W. (2020) · Journal of Virology · doi:10.1128/jvi.00093-20 · Cited by 8
Boulton, S., Crupi, M. J. F., Singh, S., Carter-Timofte, M. E., Azad, T., Organ, B. C., He, X., Gill, R., Neault, S., Jamieson, T. R., et al. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104749 · Cited by 8
Tate, J., & Gollnick, P. D. (2015) · Virology · doi:10.1016/j.virol.2015.05.008 · Cited by 6
The Development of Silver Nanoparticles as Antiviral Agents
Trefry, J. C. (2011) · CORE Scholar (Wright State University) · Cited by 6
A novel strategy to express different antigens from one modified vaccinia Ankara vaccine vectorPreprint
Lauer, K. B., McKenzie, E. A., Hall, Y., Gowda, C. P. C., Klapper, P. E., Borrow, R., Vallely, P. J., Carroll, M. W., & Blanchard, T. J. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/191924 · Cited by 1
The Role of AMPK in Viral Infection
Moser, T. S. (2011) · ScholarlyCommons (University of Pennsylvania)
Poxvirus Entry into Host Cells
Moss, B., Bengali, Z., Bisht, H., Laliberte, J. P., & Satheskumar, P. S. (2010) · Springer eBooks · doi:10.1007/978-90-481-9054-6_11
“It was found that the A16 and G9 proteins of the EFC interact with A56-K2 and that this interaction prevents syncytium formation and also superinfection of cells by progeny VACV ( Wagenaar and Moss, 2007, 2009; Wagenaar et al., 2008).”
BackgroundSelf-citationOmics Approaches in Viral Biotechnology
Waqar, K., Irfan, R., & Gul, A. (2018) · Omics Technologies and Bio-Engineering · doi:10.1016/b978-0-12-815870-8.00002-4
“After this, the library is cleaned up, amplification and quantification is carried out, and lastly, the library is sequenced (Liu and Graber, 2006; Ozsolak and Milos, 2011; Ozsolak et al., 2009; Hickman et al., 2013).”
Pickup, D. J. (2010) · Wiley eBooks · doi:10.1002/9780470015902.a0001083.pub2
Pox-AbDab: the orthopoxvirus antibody database
Capel, H., Wang, E. J. D., Williams, B. H., Deane, C. M., & Raybould, M. I. J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1698441
Altamura, L. A. (2008) · Scholarly Commons (University of Pennsylvania)
Metadata
- Authors
- Wagenaar, T. R., & Moss, B.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Moss, Bernard
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2007-06-15
- Volume
- 81
- Issue
- 12
- Pages
- 6286-6293
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- PMC
- PMC1900102
- OpenAlex
- W2058606755
- Cited by
- 56
- References
- 41
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 1 · 2020: 4 · 2018: 2 · 2017: 2 · 2016: 1 · 2015: 2 · 2014: 2 · 2013: 1 · 2012: 6
- FWCI
- 3.33
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Virology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
- Topics
- Life Sciences › Immunology and Microbiology › Virology › Poxvirus research and outbreaks
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Keywords
- vaccinia virus, syncytium formation, viral fusion, protein-protein interaction, heterodimer
- MeSH terms
- Cell Membrane, Genes, Viral, HeLa Cells, Humans, Hydrogen-Ion Concentration, Membrane Fusion, Mass Spectrometry, Vaccinia virus, Viral Envelope Proteins, Viral Fusion Proteins, Viral Proteins, Gene Expression Regulation, Viral, Gene Deletion, Dimerization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.